CGS encourages responsible uses and effecitve governance of human genetic and assisted reproductive technologies

Featured

Biopolitical Times

The California Institute for Regenerative Medicine (CIRM) is running out of money. It is also running out of time to prove that California’s $6 billion dollar investment in the agency was worthwhile. (Half of that money was for interest.) Current estimates are that the last grants funded by 2004’s Proposition 71 will be made in 2019.

What next? CIRM won’t immediately fold in the fourth quarter of next year; the administrative budget will run through at least 2020. But...

Op-Ed

The Nuffield Council on Bioethics has taken what it clearly regards as a brave new step: it has openly endorsed the use of genome editing to engineer the traits of future children and generations. The council’s report, Genome editing...

Op-Ed

A wave of controversy about reproductive gene editing gathered force in response to reports in 2015 of the first CRISPR...

Aggregated News

The dramatic pace of scientific discoveries in recent decades has not only led to remarkable improvements in domains such as...

Biopolitical Times

On August 13, 2018, Molecular Therapy published a report (Open Access) that explicitly “suggests the efficiency and genetic...

At irregular intervals over the last decade or so, Dr. Jeffrey Steinberg of The Fertility Institutes has used the media...

The California Institute for Regenerative Medicine (CIRM) is running out of money. It is also running out of time to...

News

By Matthew Weaver, The Guardian | 09.18.2018

The fertility regulator has called for DNA testing websites to warn customers about the risks of uncovering traumatic family secrets and underlying health traits.

Sites such as Ancestry.com, 23andMe and DNA.com offer customers the chance to discover long-lost relatives by...

By Amber Haque, BBC | 09.17.2018

Labour is calling for a ban on parents-to-be being told the sex of their baby after early blood tests, amid fears it may lead to abortions of girls.

The Non-Invasive Prenatal Test (NIPT) is used by the NHS to test...

By Laura Hercher, The New York Times | 09.15.2018

In many ways, Matt Fender, a 32-year-old resident of New York City, is the prototypical 23andMe customer: tech-savvy, educated, a bit of a worrier. But he wasn’t worried last December when he clicked a button to dump all the raw...

By Jessica Hekman, Undark | 09.13.2018

The promise of a sequenced genome is like a wrapped present, containing exactly what you always wanted but never knew you could get: predictions of all your future health problems and instructions for how to avoid them. Pet owners are...

Video

Where the Debate Over "Designer Babies" Began
World Forum on Science and Democracy
San Francisco discussion - Gattaca at 20: Looking Back, Looking Ahead w/ a Disability Justice Focus